tiprankstipranks
Universal Health Realty (UHT)
NYSE:UHT
Want to see UHT full AI Analyst Report?

Universal Health Realty Income (UHT) AI Stock Analysis

214 Followers

Top Page

UHT

Universal Health Realty Income

(NYSE:UHT)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 5.2)
Rating:56Neutral
Price Target:
$42.00
▲(2.26% Upside)
Action:Reiterated
Date:05/10/26
The score is driven mainly by solid cash-flow strength but offset by elevated leverage and some softening in TTM revenue/margins. Technical indicators add a modest headwind due to negative momentum and below-short-term moving averages, while valuation is mixed with a high dividend yield balanced against a relatively high P/E.
Positive Factors
Strong free cash flow generation
UHT’s improved trailing‑12‑month free cash flow reflects steady operating cash conversion typical of net‑lease REITs. Reliable FCF supports distributions, funds maintenance capex and selective redevelopment, and provides durable internal liquidity for debt service and opportunistic investments.
Negative Factors
Elevated and rising leverage
A debt-to-equity above ~2.6x materially increases interest‑rate and refinancing exposure for a REIT. Higher leverage constrains financial flexibility, raises cost of capital, and amplifies downside risk if tenant cash flows soften, limiting ability to pursue growth without issuing equity.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong free cash flow generation
UHT’s improved trailing‑12‑month free cash flow reflects steady operating cash conversion typical of net‑lease REITs. Reliable FCF supports distributions, funds maintenance capex and selective redevelopment, and provides durable internal liquidity for debt service and opportunistic investments.
Read all positive factors

Universal Health Realty Income (UHT) vs. SPDR S&P 500 ETF (SPY)

Universal Health Realty Income Business Overview & Revenue Model

Company Description
Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service related facilities including acute care hospitals, rehabilitation hospitals, sub-acute care facilities, medical/office buildings, free-st...
How the Company Makes Money
UHT makes money primarily by owning healthcare real estate and generating recurring rental income from leasing those properties to healthcare operators. Its key revenue stream is contractual rent payments under long-term leases (often structured a...

Universal Health Realty Income Financial Statement Overview

Summary
Cash generation is a key support (cash flow score 70) with improved TTM free cash flow, but the balance sheet is a meaningful constraint (score 48) due to elevated and rising leverage. Income statement trends are mixed (score 62) with slightly softer TTM revenue/margins versus prior years.
Income Statement
62
Positive
Balance Sheet
48
Neutral
Cash Flow
70
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue148.66M99.19M99.01M95.58M90.63M84.19M
Gross Profit134.52M93.59M93.53M90.25M85.53M79.78M
EBITDA64.11M67.58M70.49M65.16M58.41M145.45M
Net Income17.85M17.61M19.23M15.40M21.10M109.17M
Balance Sheet
Total Assets563.76M564.91M580.86M596.37M607.54M598.42M
Cash, Cash Equivalents and Short-Term Investments7.06M6.69M7.10M8.21M7.61M22.50M
Total Debt389.19M386.03M379.17M370.41M354.28M340.26M
Total Liabilities415.96M412.52M401.32M395.44M378.44M363.09M
Stockholders Equity147.80M152.38M179.54M200.93M229.10M235.33M
Cash Flow
Free Cash Flow49.43M49.09M46.91M43.47M33.19M34.74M
Operating Cash Flow49.43M49.09M46.91M43.47M46.80M47.73M
Investing Cash Flow-17.52M-14.96M-13.88M-19.87M-36.67M-24.43M
Financing Cash Flow-31.82M-34.55M-34.15M-23.01M-25.02M-6.54M

Universal Health Realty Income Technical Analysis

Technical Analysis Sentiment
Positive
Last Price41.07
Price Trends
50DMA
41.20
Positive
100DMA
40.89
Positive
200DMA
39.33
Positive
Market Momentum
MACD
<0.01
Negative
RSI
60.69
Neutral
STOCH
86.34
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UHT, the sentiment is Positive. The current price of 41.07 is above the 20-day moving average (MA) of 40.68, below the 50-day MA of 41.20, and above the 200-day MA of 39.33, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 60.69 is Neutral, neither overbought nor oversold. The STOCH value of 86.34 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for UHT.

Universal Health Realty Income Risk Analysis

Universal Health Realty Income disclosed 33 risk factors in its most recent earnings report. Universal Health Realty Income reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Universal Health Realty Income Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$2.00B19.1111.79%6.70%48.96%28.05%
72
Outperform
$1.67B26.062.81%6.98%9.37%6.95%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
62
Neutral
$501.15M42.081.41%12.08%5.24%
61
Neutral
$2.21B-18.75%0.80%0.39%-8.95%
56
Neutral
$580.42M27.8911.44%7.51%0.77%-4.74%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
UHT
Universal Health Realty Income
42.12
6.87
19.50%
LTC
LTC Properties
38.64
5.91
18.04%
DHC
Diversified Healthcare Trust
8.90
5.92
198.26%
CHCT
Community Healthcare
17.72
3.52
24.79%
SILA
Sila Realty Trust, Inc.
30.25
7.36
32.16%

Universal Health Realty Income Corporate Events

Business Operations and StrategyRegulatory Filings and Compliance
Universal Health Realty Income Enters New Material Agreement
Neutral
Apr 24, 2026
Universal Health Realty Income disclosed that information from its disclosure about entering a material definitive agreement has been incorporated by reference into another section of its filing. This indicates the company is cross-referencing key...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 10, 2026